Evaluation of patients whose HCV serology was investigated in our hospital between 2010-2018

HCV infection is commonly asymptomatic, most people infected with HCV are not aware that they are infected, and most of those who receive a diagnosis also currently cannot reach treatment. Our study, it was aimed to appreciate the rate of anti-HCV-positive patients and the awareness and knowledge of patients about their hepatitis C follow-up or treatment. In this study, we evaluated 56.115 patients who were screened for anti-HCV tests retrospectively. The patients who have positive HCV RNA tests with anti-HCV tests and without having HCV RNA test results were attempted to reach by phone. Anti-HCV positivity was determined in 708 (1.3%) patients. The mean age of 708 patients (Female, n=415;58.6%, and male, n=293;41.4%) was 63 years. Anti-HCV was positive in 708 patients, HCV RNA test was positive in 324 (45.8%) patients and negative in 163 (23.0%) patients. In 221 (31.2%) patients with positive of anti-HCV tests. The distribution rates of the requesting HCV RNA test in departments were: 41.8% in the infectious department, 39.4% in the internal department, 18.8% in the surgery department. Among 324 patients, 65 of them were phoned. Among 65 patients, 14 of them were being treated in another center, 11 of them were treated in our hospital. Among 221 patients who were not tested for HCV RNA 74 of them were phoned. Among 74 patients, 16 of them were being treated in another center and 7 of them were treated in our hospital. We found that the knowledge of physicians about HCV screening and treatment is low in the eradication of HCV. This situation emerged as the most important limitation of the study. Therefore, education programs about the notification of the HCV cases to the doctors for diagnosis and treatment may be beneficial.

[1]  H. Köseoğlu,et al.  Physician awareness of hepatitis C virus among different departments , 2020, Clinical and experimental hepatology.

[2]  C. Silvestri,et al.  Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination , 2020, SN Comprehensive Clinical Medicine.

[3]  D. Mert,et al.  Hepatitis C screening and referral for further investigation and treatment in a tertiary care hospital. , 2020, Journal of infection in developing countries.

[4]  E. Tigen,et al.  Chronic Hepatitis C Prevalence, Genotype Distribution and Treatment Responses at Marmara University Pendik Training and Research Hospital Between 2014-2018 , 2020 .

[5]  N. Tunc Chronic Hepatitis C Prevalence and Physician Awareness in Southeastern Turkey , 2019 .

[6]  F. Ateş,et al.  Patients Lost after Anti-HCV-Positive Finding in a Tertiary Care University Hospital: Increased Awareness and Action is Necessary to Eradicate HCV , 2019, Sisli Etfal Hastanesi tip bulteni.

[7]  Sanjeev Arora,et al.  The ECHO model proved to be a useful tool to increase clinicians' self‐effectiveness for care of patients with Hepatitis C in Argentina , 2019, Journal of viral hepatitis.

[8]  M. Ağın,et al.  Chronic hepatitis C infection: how much are physicians aware of? , 2019, Przeglad gastroenterologiczny.

[9]  D. Turan,et al.  Seroprevalence of HBsAg and anti-HCV for patients who admitted to third step hospital: Six-year retrospective data , 2019 .

[10]  N. Terrault Hepatitis C elimination: challenges with under-diagnosis and under-treatment , 2019, F1000Research.

[11]  J. Ward,et al.  The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals , 2019, Journal of virus eradication.

[12]  F. Chisari,et al.  Is Elimination of Hepatitis B and C a Pipe Dream or Reality? , 2019, Gastroenterology.

[13]  Jean-Michel Pawlotsky,et al.  EASL Recommendations on Treatment of Hepatitis C 2018. , 2018, Journal of hepatology.

[14]  J. Ward,et al.  Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework , 2018, Journal of virus eradication.

[15]  F. Chisari,et al.  Is Elimination of Hepatitis B and C a Pipe Dream or Reality? , 2018, Gastroenterology.

[16]  U. Akarca,et al.  Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  J. Feld,et al.  Hepatitis C virus infection , 2015, Canadian Medical Association Journal.

[18]  O. Karadag,et al.  Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital , 2014 .

[19]  J. Ward,et al.  Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward) , 2014, Journal of viral hepatitis.

[20]  Lai Wei,et al.  Inadequate awareness of hepatitis C among nonspecialist physicians in China , 2011, Advances in medical education and practice.

[21]  Ş. Şahin,et al.  Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study. , 2009, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.